We are live on ! Find out more
PMVP icon

PMV Pharmaceuticals
PMVP

111 hedge funds and large institutions have $246M invested in PMV Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $161K | Put options by funds: $99K

26% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

3% less funds holding

Funds holding: 115 → 111 (-4)

6.94% less ownership

Funds ownership: 119.42% → 112.49% (-6.9%)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

48% less capital invested

Capital invested by funds: $470M → $246M (-$224M)

Holders
111
Holders Change
-4
Holders Change %
-3.48%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
44
Reduced
35
Closed
17
Calls
$161K
Puts
$99K
Net Calls
+$62K
Net Calls Change
-$1.09M

Top Buyers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
+$9.68M
2
BlackRock
BlackRock
New York
+$4.07M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$3.04M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.84M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.97M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$17.8M
2
RI
RTW Investments
New York
-$9.56M
3
NI
Nextech Invest
Switzerland
-$6.08M
4
WP
Woodline Partners
California
-$5.86M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$5.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHS
26
PFM Health Sciences
California
$1.99M +$593K +84,311 +25%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$1.94M -$881K -125,237 -24%
Millennium Management
28
Millennium Management
New York
$1.63M +$1.89M +268,615 +365%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$1.63M +$1.97M +279,921 +458%
BBA
30
Baker Bros. Advisors
New York
$1.54M – – –
Northern Trust
31
Northern Trust
Illinois
$1.47M -$86K -12,227 -4%
HF
32
HRT Financial
New York
$1.4M +$967K +137,450 +89%
E
33
Ergoteles
New York
$1.23M +$1.65M +234,447 +1,004%
Squarepoint
34
Squarepoint
New York
$1.22M +$1.68M +238,395 +1,312%
Barclays
35
Barclays
United Kingdom
$1.22M +$659K +93,603 +58%
Charles Schwab
36
Charles Schwab
California
$1.21M +$10.7K +1,515 +0.6%
SAM
37
Sectoral Asset Management
Quebec, Canada
$1.19M +$1.76M +250,469 New
Vontobel Holding
38
Vontobel Holding
Switzerland
$1.19M +$1.76M +250,469 New
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$1.19M +$824K +117,062 +88%
Jane Street
40
Jane Street
New York
$1.12M +$1.15M +162,927 +225%
SFM
41
Sphera Funds Management
Israel
$896K – – –
WP
42
Woodline Partners
California
$839K -$5.86M -832,799 -83%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$744K +$284K +40,369 +35%
ACP
44
Acuta Capital Partners
California
$737K – – –
Two Sigma Investments
45
Two Sigma Investments
New York
$653K +$865K +122,950 +878%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$584K -$1.96K -279 -0.2%
NYLIM
47
New York Life Investment Management
New York
$445K +$657K +93,363 New
UBS Group
48
UBS Group
Switzerland
$428K -$1.37M -194,744 -68%
PP
49
PDT Partners
New York
$421K +$154K +21,945 +33%
N
50
Nuveen
North Carolina
$420K -$74.6K -10,600 -11%
1
2
3 4 5

PMVP Hedge Fund Activity: Q1 2023 in Review

111 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in PMV Pharmaceuticals (PMVP) for Q1 2023, worth a combined $246M — down 48% from $470M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of PMVP and 14 opened new positions — a net loss of 3 holders — while 35 trimmed existing stakes and 44 added.

The largest buyer was Verition Fund Management, adding an estimated $9.68M. The largest seller was State Street, cutting an estimated $17.8M.

  • 111 institutional investors held PMV Pharmaceuticals (PMVP) as of Q1 2023, down from 115 in Q4 2022.
  • Funds reported $246M of PMV Pharmaceuticals stock for Q1 2023, down 48% quarter-over-quarter.
  • 14 funds opened new PMV Pharmaceuticals positions in Q1 2023 and 17 closed out, a net change of -3 holders.
  • The largest PMV Pharmaceuticals buyer in Q1 2023 was Verition Fund Management, an estimated $9.68M added.
  • The largest PMV Pharmaceuticals seller in Q1 2023 was State Street, an estimated $17.8M sold.

Based on aggregated 13F filings for Q1 2023.